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Validation of the Aids Prevention Questionnaire 
Resumen 
Este artículo describe el proceso de construcción y validación del Cuestionario para la 
Prevención del Sida (CPS), un instrumento breve de evaluación del riesgo de infección 
por VIH. Un banco inicial de 64 ítems fue cumplimentado por 466 jóvenes (192 
hombres y 274 mujeres), con edades comprendidas entre 17 y 26 años (M = 20.62; DT = 
2.15). El análisis factorial exploratorio reveló cinco componentes: información y 
conocimientos sobre VIH, autoeficacia percibida en el uso del preservativo, intención 
de uso del preservativo, uso autoinformado del preservativo y solidaridad y empatía 
hacia las personas que viven con VIH. Esta estructura fue ratificada mediante análisis 
factorial confirmatorio. La consistencia interna para los distintos componentes osciló 
entre .67 y .74. Además, el CPS presenta un sistema de clasificación que permite 
determinar el nivel de riesgo. Estos resultados indican que el Cuestionario para la 
Prevención del Sida es un instrumento válido y fiable para la detección temprana del 
nivel de riesgo para la infección por VIH y para el diseño de intervenciones preventivas 
personalizadas. 
 
Palabras clave: prevención del VIH, conducta sexual de riesgo, nivel de riesgo, 
propiedades psicométricas, intervenciones preventivas 
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Abstract 
This paper describes the process of building and validating the AIDS Prevention 
Questionnaire (CPS), a brief HIV risk assessment measure. An initial 64-items bank 
was filled out by 466 young people (192 men and 274 women), aged between 17 to 26 
years (M= 20.62; SD = 2.15). The exploratory factor analysis revealed five components: 
Knowledge about HIV, Condom Attitudes, Intentions of Condom Use, Safe sexual 
behavior and Stigma and discrimination towards people living with HIV. This structure 
was confirmed by confirmatory factor analysis. The internal consistency for the 
different components ranged from .67 to .74. Moreover, CPS has a classification system 
that allows determining the level of risk. These results support the AIDS Prevention 
Questionnaire as a valid and reliable measure to detect earlier the risk for HIV infection 
and to design adjusted preventive interventions. 
 
Keywords: HIV prevention, sexual risk behavior, level of risk, psychometric properties, 
preventive interventions  
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Validation of the Aids Prevention Questionnaire 
Introduction 
HIV/AIDS remains one of the most serious global health problems. At this 
moment, global rate of new HIV diagnoses in Spain is 7.2 per 100,000 population [1]. 
The information system for new HIV diagnoses (SINIVIH) reported 3,353 new HIV 
diagnoses last year, as well as 86.663 people living with HIV in Spain. New HIV 
diagnoses are mainly related to sexual transmission. In particular, transmission in men 
who have sex with men (MSM) was the most frequent route of infection (53.1%), 
followed by heterosexual transmission, which represented 26.5%, and injecting drug 
users (IDU), who made up 3.6%. Men represented 83.9% of new HIV diagnoses in 
2016 and the mean rates for men and women were 12.3 and 2.2 per 100,000 population. 
Young people under 30 years account for 25.8% of new infections. Furthermore, 46% 
showed signs of delayed diagnosis (with less than 350 CD-4 cells), even though HIV 
testing is available, confidential and free of charge for everybody [2]. 
Nowadays, surveillance on AIDS cases shows that epidemic is based primarily 
on risky sexual behaviors. Different behavioral change theories have developed a 
conceptual framework for HIV prevention. The Health Belief Model (HBM) [3], the 
Theory of Reasoned Action (TRA) [4] or Planned Behavior (TPB) [5], the Information-
Motivation-Behavioral Skills Model (IMB) [6], and the Social Cognitive Theory (SCT) 
[7], have been the most relevant in this field of knowledge. Each of them has identified 
a number of constructs that would be predictors of sexual risk behavior [8].  
In these decades, multiple scales and questionnaires have been published in 
different countries that evaluate the main components of these models (see Table 1): 
beliefs and attitudes (for example: Multidimensional Condom Attitudes Scale [9]; HIV-
Antibody Testing Attitude Scale [10];  HIV/AIDS Attitudes Scale [11]; HIV/AIDS 
Stigma Scale [12]; Condom Use Expectancy Scale [13]; Condom Barriers and 
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Motivations Scale [14], HIV Attitudes Scale [15]), knowledge and information (for 
example: HIV Knowledge Questionnaire [16]; HIV and other STI Knowledge Scale 
[17]), self-efficacy (for example: Condom Use Self-Efficacy Scale [18]; Specific 
Condom Use Self-efficacy [19]; Modified Condom Outcome Expectancy Scale  [20]; 
Condom Use Self-efficacy Measure [21]), perception of risk (for example: Fear of 
AIDS Instrument [22]; Risk-Taking Questionnaire [23]; Perceived Risk of HIV Scale 
[24]; Multicomponent AIDS Phobia Scale [25], Worry about Sexual Outcomes [26]); or 
behavior and behavioral intention (for example: The Safe Sex Behavior Questionnaire 
[27]; Condom Influence Strategy Questionnaire [28]; HIV Risk Behavior Questionnaire 
[29]; HIV-Risk Index [30]). 
Others questionnaires have been based on some models: HBM (AIDS Health 
Belief Scale) [31]), IMB (ES 5 Questionnaire) [32]) or TPB (Sexual Risk Behavior 
Scale [33]). The others measure a series of constructs related to different theoretical 
approaches [34-41]. All of them have adequate psychometric properties, are usually 
written in English, the number of items range from 30 to 170 and include three to seven 
components.  
There are some unidimensional scales mentioned above in the Spanish context 
[15, 17, 25, 26]. The adaptation of the HIV/AIDS-164 Scale [37] by Bermúdez et al. 
[42], is composed of factual knowledge, misconceptions, attitudes, perceived 
susceptibility, and self-efficacy. The HIV-Risk Index by Ballester-Arnal et al. [30] 
estimates HIV risk exposure among young people through a global score based on 
direct and indirect indicators. 
After reviewing literature (see Table 1), we have not found a brief 
multidimensional assessment measure in which all theoretical perspectives are 
integrated, broader vision of risk behavior for HIV infection is provided (knowledge, 
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attitudes towards HIV and safe sex, self-efficacy, behavioral intention, preventive 
behavior and stigma towards people living with HIV), and health care professionals 
were supported to make a more extensive use, for example to make decisions about 
specifics interventions actions. The AIDS Prevention Questionnaire (CPS) has two 
purposes: firstly, the diagnosis of risk profile for HIV infection, and secondly, the 
design, planning and evaluation of the effectiveness of preventive interventions to 
change sexual risk behavior. CPS integrates quantitative and qualitative assessment 
methods. In the present study, the construction and validation of a descriptive and 
explanatory measure of risk behavior for HIV/AIDS addressed to adolescents and 
young Hispanics is presented. 
INSERT TABLE 1  
Method 
Participants 
Four hundred and sixty-six Spanish young people were assessed (58.8% were women 
and 41.2% were men) in different activities organized by XXX. The age ranged 
between 17 and 26 years (Mage = 20.62; SD = 2.15). Most of them self-identified as 
heterosexual (females: 93%; males: 88%) and some of them as homosexual (females: 
2%; males: 9%) or bisexual (females: 5%; males: 3%). Regarding country of origin, 
98% were Spanish and 2% were from other countries. Concerning sexual experience, 
89.9% of participants reported mutual masturbation, followed by vaginal sex (88.8%), 
oral sex (87.1%) and anal sex (30.5%). 
Measures 
AIDS Prevention Questionnaire (Cuestionario de Prevención del Sida or CPS) is 
a self-administered measure that includes 44 different response format questions: 14 
dichotomous items, 2 multiple choice items, 24 Likert-type items and 4 continuous 0 to 
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Validation of the Aids Prevention Questionnaire 
100 items. The questionnaire considers HIV/AIDS prevention as a multidimensional 
perspective and uses the sociocognitive models of health behavior as theoretical 
reference. The main components are information and knowledge about HIV (12 items), 
attitudes and perceived self-efficacy (14 items), behavioral intention condom use (6 
items), self-reported use of condom and HIV antibody testing (7 items), and solidarity 
and empathy towards people living with HIV (5 items). 
Description of the CPS domains: 
1. Knowledge about HIV (K-HIV). A series of statements about the level of perceived 
information (items 1, 2 and 10), real knowledge about routes of transmission and risky 
practices (items 7 and 8), types of information sources (item 3), preventive measures 
(item 9), HIV antibody testing (items 11 and 12), and the impact of disease in people 
living with HIV (items 4, 5 and 6). 
2. Self-efficacy and attitudes (SEA). A series of statements that describe ability and 
skills to use condoms such as buying, putting or refusing unsafe sexual intercourse 
(item 13, 18, 20 and 21), and feelings related to sexual communication (item 14, 15 and 
16), influence of drugs and sexual excitation on the use of condoms (item 17 and 19). 
Moreover, some items ask about perceived probability and fear of disease and perceived 
severity (item 22, 23 and 24), subjective norm (item 26) and trust on condoms (item 25) 
are included. 
3. Condom use intention (CUSEI). A series of statements that measure behavioral 
intention of condom use in different sexual practices (item 27, 28 and 29), types of 
partner (item 30 and 31) and risk scenarios (item 32).  
4. Safe sexual behavior (SAS-B). A series of self-reported statements about frequency 
of condom use in different sexual practices (item 33, 34 and 35), types of partner (item 
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36 and 37) and risk scenarios (item 38). Moreover, 1-item related to get HIV antibody 
testing (item 39) is included.  
5. Stigma and discrimination towards people living with HIV (SD-HIV). A series of 
statements that measure solidary behavior towards known and unknown people living 
with HIV (item 42, 43 and 44). Moreover, items related to empathy and social 
perception of HIV-positive people (item 40 and 41) are included. 
Procedure 
In order to design the assessment tool, a group of experts in health psychology 
generated a set of statements that represented the main keys of the theoretical models of 
HIV prevention. Two experts extensively reviewed a bank of 64 items. The quality 
criteria were syntactic correction, semantic comprehension and adequacy of statements 
to the construct. The experts evaluated each item scoring from 0 to 5. Questions that had 
formulation problems were deleted, some statements were rewritten using alternative 
expressions, and items with similar content were grouped. The corrected version of the 
instrument was administered to a pilot group. The final version was composed of 44 
items. 
Participants were collected during the World AIDS Day. The research unit 
carries out informative and formative activities on the 1st December each year. They 
were aimed to raise awareness, disseminate knowledge and offer volunteer programs to 
the young people. Specifically, diptychs on participation about HIV research projects 
were offered to interested people during 2016. In the first phase, these young people 
were contacted by the mean of communication preferred to provide them information 
about the study and confirm their participation (two months). In the second phase, 
groups of 6-7 participants filled questionnaires in a paper-and-pencil format, in the 
laboratories of the university research unit (four months). The approximate time to 
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complete them was ten minutes. The guidelines of the Spanish data protection law and 
the Declaration of Helsinki were applied. 
Analysis of data 
Participants were randomly divided into two sub-samples to explore and confirm 
the factorial structure. Sample 1 had 231 people (40.26% were male and 59.74% were 
female) aged 17 to 26 years (M= 20.48; SD= 2.17). They were included in the 
Exploratory Factor Analysis (EFA). Sample 2 was consisted of 235 people (42.16% 
were males and 56.84% were females) aged 17 and 26 years (M = 19.82, SD = 2.13). 
They were included in the Confirmatory Factor Analysis (CFA). No statistically 
significant gender and aged differences were found. 
Psychometric properties of the questionnaire were evaluated by the Kaiser-Meyer-
Olkin test (KMO) and Bartlett's test of sphericity, Unweighted least squares (ULS) 
method and an oblique rotation (direct Oblimin) were used for EFA, structural equation 
modeling were required for CFA, the Cronbach's α was used as a reliability index, and 
the relationship among components was calculated by the Pearson's correlation 
coefficient. The fit indices used were Satorra-Bentler scaled Chi-square (χ2S-B/df), 
Normed Fit Index (NFI), Non-normed Fit Index (NNFI), Comparative Fit Index (CFI), 
and Root Mean Square Error of Approximation (RMSEA). IBM SPSS Statistics 20.0 
and EQS 6.1 programs were used for the statistical analysis. 
Results 
Structure 
The questionnaire has five dimensions previously commented that assess the main 
components of HIV prevention. As seen in Table 2, each factor has a certain number of 
items and a minimum-maximum range of scores. The Cronbach’s alpha internal 
consistency reliability was adequate (between .67 and .74).  
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INSERT TABLE 2 
Knowledge about HIV (K-HIV) 
Results of the Kaiser-Meyer-Olkin (KMO = .702) measure of sampling adequacy 
and Bartlett's test of sphericity (χ266 = 577.672, p < .001) were appropriate for factor 
analysis. Consequently, an exploratory factor analysis by weighted least squares and 
direct Oblimin rotation was conducted. Four subfactors were extracted explaining 
52.91% of the total variance: 
- K-HIV 1, called “Level of perceived HIV-information”, was made up of 3 items 
(item 1, 2 and 3) that measured the belief about the own level of information. It explains 
21.78% of variance. 
- K-HIV 2, named “Myths about HIV/AIDS”, was made up of 3 items (item 4, 5 and 
6) that asked misconceptions about HIV infection and people living with HIV. It 
explains 10.52% of variance. 
- K-HIV 3, called “Level of HIV-information”, was made up of 3 items (item 7, 8 
and 9) that evaluated the knowledge about routes of HIV transmission. It explains 
10.87% of variance. 
- K-HIV 4, named “HIV antibody testing knowledge”, was made up of 3 items (item 
10, 11 and 12) that examined the information about diagnosis of HIV. It explains 9.74% 
of variance. 
Confirmatory factor analysis was conducted. The indexes related to the model 
seemed to be a good fit to the data: χ2S-B/df = 1.213, NNFI = .963, CFI = .973; RMSEA 
= .022.  In this factor, the Cronbach's alpha obtained was .673.  
Self-efficacy and attitudes (SEA) 
Results of the Kaiser-Meyer-Olkin (KMO = .679) measure of sampling adequacy 
and Bartlett's test of sphericity (χ266 = 604.364, p < .001) were appropriate for factor 
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analysis. Consequently, an exploratory factor analysis with weighted least squares and 
direct oblimin rotation was conducted. Three subfactors were extracted explaining 
55.79% of the total variance: 
- SEA 1, called “Comfort in condom use”, was made up of 5 items (item 13, 14, 17, 
18 and 19) that assessed the level of safety and feeling of comfort with the condom. It 
explains 28.33% of variance. 
- SEA 2, named “Condom use negotiation”, was made up of 2 items (item 15 and 16) 
that evaluated the fear of partner rejection after requesting the use of condom. It 
explains 11.63% of variance. 
- SEA 3, called “knowledge about how to use condoms”, was made up of 2 items 
(item 20 and 21) that examined the knowledge of how to put on a condom correctly. It 
explains 15.80% of the variance. 
Confirmatory factor analysis was conducted. The indexes related to the model 
seemed to be a good fit to the data: χ2S-B/df = 1.532, NNFI = .958, CFI = .972, RMSEA 
= .035. The Cronbach's alpha obtained in this factor was .699.  
Condom Use Intentions (CUSEI) 
Results of the Kaiser-Meyer-Olkin (KMO = .742) measure of sampling adequacy 
and Bartlett's test of sphericity (χ266 = 189.997, p < .001) were appropriate for factor 
analysis. Consequently, an exploratory factor analysis with weighted least squares and 
direct oblimin rotation was conducted. Two subfactors were extracted explaining 
62.93% of the total variance: 
- CUSEI 1, named “Behavioral intention to condom use in different sexual 
practices”, was made up of 4 items (item 27, 28, 29 and 30) that assessed the motivation 
to use a condom in romantic relationships. It explains 43.99% of variance. 
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- CUSEI 2, called “Behavioral intention to condom use with casual partner and drugs 
consumption”, was made up of 2 items (item 31 and 32) that evaluated the motivation to 
use a condom in occasional relationships. It explains 18.94% of variance. 
Confirmatory factor analysis was conducted. The indexes related to the model 
seemed to be a good fit to the data: χ2S-B/df = 1.525, NNFI = .934, CFI = .956, RMSEA 
= .061. In this factor, the Cronbach's alpha obtained was .739.  
Safe sexual behavior (SAS-B)  
Results of the Kaiser-Meyer-Olkin (KMO = .633) measure of sampling adequacy 
and Bartlett's test of sphericity (χ266 = 152.388, p < .001) were appropriate for factor 
analysis. Consequently, an exploratory factor analysis with weighted least squares and 
direct oblimin rotation was conducted. Three subfactors were extracted explaining 
74.91% of the total variance: 
- SAS-B 1, called “Vaginal intercourse”, was made up of 2 items (item 33 and 36) 
that assessed the use of condom in vaginal sexual practices. It explains 39.13% of 
variance. 
- SAS-B 2, named “Anal and oral intercourse”, was made up of 2 items (item 34 and 
35) that evaluated the use of condom in oral and anal sexual practices. It explains 
18.74% of variance. 
- SAS-B 3, called “Occasional intercourse”, was made up of 2 items (item 37 and 38) 
that examined the use of condom with sporadic partners and under alcohol and drugs 
effects. It explains 17.03% of variance. 
Confirmatory factor analysis was conducted. The indexes related to the model 
seemed to be a good fit to the data: χ2S-B/df = 1.577, NNFI = .939, CFI = .975, RMSEA 
= .068. The Cronbach's alpha obtained in this factor was .674.  
Stigma and discrimination towards people living with HIV (SD-HIV) 
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Validation of the Aids Prevention Questionnaire 
Results of the Kaiser-Meyer-Olkin (KMO = .675) measure of sampling adequacy 
and Bartlett's test of sphericity (χ266 = 287.081, p < .001) were appropriate for factor 
analysis. Consequently, an exploratory factor analysis with weighted least squares and 
direct Oblimin rotation was conducted. Two subfactors were extracted explaining 
64.28% of the total variance: 
- SD-HIV 1, called “Empathy”, was made up of 2 items (item 40 and 41) that 
assessed the capacity to understand how people live with HIV, that is, the social 
perception about the feeling that HIV positive people are experiencing. It explains 
36.15% of variance. 
- SD-HIV 2, named “Solidarity”, was made up of 3 items (item 42, 43 and 44) that 
evaluated the predisposition to help a friend living with HIV. It explains 28.13% of 
variance. 
Confirmatory factor analysis was conducted. The indexes related to the model 
seemed to be a good fit to the data: χ2S-B/df = 1.877, NNFI = .952, CFI = .965, RMSEA 
= .076. The Cronbach's alpha obtained in this factor was .689.  
Finally, it should be highlighted that the statistical analysis of items 22, 23, 24, 25, 
26 and 39 have not allowed to include them in these previous dimensions. However, 
they are maintained because their content are relevant for a comprehensive assessment 
of the preventive aspects of HIV and evaluate main aspects of the theoretical models of 
HIV prevention. They will be have a qualitative analysis and interpretation. 
Normative Data and Correlations 
Significant statistical differences by gender are found in SD-HIV (p = .008) and 
CUSEI (p= .021). Females obtained higher scores than males in stigma and 
discrimination towards people living with HIV and condom use intentions (see Table 3).  
INSERT TABLE 3 
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Validation of the Aids Prevention Questionnaire 
Moreover, all components were related to each other with values ranging from 
.122 to .499. As Table 4 shows, there are positive correlations between condom 
attitudes and knowledge about HIV (p=.001), safe sexual behavior (p=.002), and stigma 
and discrimination towards people living with HIV (p=.016). Moreover, condom use 
intentions and safe sexual behavior showed positive correlations (p=.001). 
INSERT TABLE 4 
Classification of the scores 
A classification system that allows applying a descriptive label to each dimension is 
showed. The mean T-score range on all scales is from 41 to 59 points. Low scores are 
within one or two standard deviations of the mean. They indicate deficits in any 
component; therefore, there is a risk for sexual health. Very low scores are within two 
or more standard deviations of the mean. They indicate significant problems in any 
component, thus, an increment of the risk to HIV infection (see Table 5). 
INSERT TABLE 5 
Discussion 
This study evaluated the psychometric properties of a brief AIDS Prevention 
Questionnaire in a sample of Spanish youth. AIDS is a challenge for public health, 
especially in groups such as MSM or heterosexuals [1, 2]. Correctly and consistent 
condom use in sexual relationships is the only effective procedure for HIV prevention, 
other sexually transmitted infections and unwanted pregnancies. The behavior changes 
models have explained the sexual risk behavior through psychosocial determinants [3-
7]. It is necessary to design brief and easy-apply assessment measures to score broadly 
the risk factors for HIV infection in the clinical, educational and health settings. Most of 
the assessment measures reviewed are in English language. There is only one other 
multi-component questionnaire adapted to the Spanish context, the HIV/AIDS Scale 
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Validation of the Aids Prevention Questionnaire 
164 by Paniagua. But it has 164 items or 65 in the brief version, and it does not include 
a behavioral component [37, 42]. The other scales found measure a single component of 
HIV prevention, for example: HIV knowledge [16], AIDS phobia [25] or HIV risk 
perception [26]. 
Our results support a questionnaire that includes 5 factors with adequate internal 
consistency (between .67 and .74). The first factor is called Knowledge about HIV (K-
HIV), it has 12 items referred to knowledge about the HIV transmission routes and the 
HIV-antibody testing, the perceived information or the misconceptions about the 
disease. This factor explains 51.91% of variance and has a reliability of 0.67. The 
second factor is named Condom Attitudes (CATT), it has 9 items related to the 
perceived competence, feeling of comfort and security with the condom (for example: 
buy it, put it on, talk about it, etc.) and fear of rejection for proposing its use to a 
partner. In this line, Weeks and cols. in 1995, identified the multidimensionality of self-
efficacy (use and rejection) [43]. This factor explains 55.79% of variance and it has a 
reliability of 0.70. The third factor is called Condom Use Intention (CUSEI), it has 6 
items and is the motivational component of the behavior. After statistical analysis, 
behavioral intention for condom use with steady partner or in casual relationships have 
appeared to be as two components separately, maybe because different contextual 
factors are influencing in each scenario. This factor explains 62.93% of variance and 
has a reliability of 0.74. Similarly, the fourth factor named Safe sexual behavior (SAS-
B) is grouped according to the frequency of condom use. Perhaps this structure relates 
to the lesser or greater perceived ability to discuss condom use with a partner. It has 6 
items, explains 74.91% of variance and has a reliability of 0.67. The last factor, called 
Stigma and discrimination towards people living with HIV (SD-HIV), has 5 items that 
are subdivided into the attitudinal sphere (empathy) and the behavioral sphere 
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Validation of the Aids Prevention Questionnaire 
(willingness to help a person with HIV). This factor explains 64.28% of variance and 
has a reliability of 0.69. 
These factors explain a high percentage of total variance and they are conceptually 
related to each other. Behavioral intention predicts behavior according to the Theory of 
Planned Behavior, it is associated to condom use in studies such as those of Jemmott et 
al. [33] or Asare [44]. Appropriate knowledge about HIV prevention is the main 
variable to analyze the risk and feel competent to use the condom in sexual interactions 
[45]. Moreover, feeling competent to use condoms also facilitates its use directly [46, 
47].  
These findings have limitations that must be addressed in the future studies. First, the 
questionnaire does not include a factor with the assessment of an attitudinal component. 
Therefore, it is recommended to use the qualitative part of the questionnaire that asked 
about perceived susceptibility, perceived severity, perceived fear, or subjective norm, by 
which professionals may assess the cognitive-affective characteristics of the sexual risk 
behavior. Secondly, it would be necessary to analyze the test-retest reliability and 
discriminant validity.  
However, this research offers a brief and valid evaluation measure that can be adapted 
to the needs of health professionals: to identify groups at risk for HIV infection, to 
design prevention programs or psychological intervention aimed at deficient areas, and 
to evaluate the effectiveness of treatments applied, identifying what components have 
changed and what ones have been resistant to change. 
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Table 2. Questionnaire components, number of statements, score range and Cronbach’s 
alpha  
Component Item 
Minimum and 
maximum values 
α 
K-HIV 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 0 – 24 .67 
SEA 13, 14, 15, 16, 17, 18, 19, 20, 21 9 – 54 .70 
CUSEI 27, 28, 29, 30, 31, 32 0 – 18 .74 
SAS-B 33, 34, 35, 36, 37, 38 0 – 18 .67 
SD-HIV 40, 41, 42, 43, 44 0 – 206 .69 
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Table 3. Descriptive statistics and gender differences (t-test) 
Component 
M (SD) 
t Total sample                            
(n = 466) 
Male
(n = 192) 
Female 
(n = 274) 
K-HIV 17.85 (3.12) 18.09 (2.95) 17.67 (3.24) 1.352 
SEA 45.01 (5.71) 44.71 (5.73) 45.23 (5.69) -.935 
CUSEI 12.81 (3.71) 12.25 (3.43) 13.74 (3.99) -2.342* 
SAS-B 9.44 (3.40) 9.16 (3.53) 9.78 (3.24) -1.010 
SD-HIV 176.76 (27.45) 172.50 (30.34) 179.64 (24.96) -2.647** 
*p < .05; **p < .01 
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Table 4. Pearson's correlation coefficient between questionnaire components 
 K-HIV SEA CUSEI SAS-B SD-HIV 
K-HIV -- .220*** -.023 .119 -.005 
SEA  -- .034 .282** .122* 
CUSEI   -- .499*** .011 
SAS-B    -- -.017 
SD-HIV     -- 
*p < .05; **p < .01; ***p < .001 
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Table 5. Profiling scores 
K-HIV SEA CUSEI SAS-B SD-HIV T-scores 
>23 >52 
>17 
>17 >205 <70  Very high 
20-22 51 13-16 - 60-69  High 
14-19 40-50 10-16 7-12 150-204 41-59  Average range 
11-13 34-39 7-9 3-6 122-149 31-40  Low 
<10 <33 <5 <2 <121 <30  Very low 
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 Table 1. Summary of tools for assessing main components of HIV prevention 
 
Name Year Authors Location Population No. Of 
items 
Subscales Alpha de 
Cronbach 
Condom Use Self-
Efficacy Scale [18] 
1991 L.J. Brafford and K.H. Beck USA 803 college students 28-items 1: personal experience with 
condoms, 2: embarrassment 
at purchase, 3: alcohol use, 
4: not wanting to offend 
with the implication of 
uncleanliness, 5: reduction 
in excitement, 6: loss of 
spontaneity, 7: breaking the 
mood, 8: not being prepared, 
9: unsure of partner's feeling 
about condoms, 10: 
embarrassment, 11: 
communication with partner, 
12: embarrassment about 
talking about condoms, 13: 
afraid of partner's refusal of 
condom use, 14: ability to 
maintain an erection, and 15: 
fear of reputation 
.91 
The Safe Sex Behavior 
Questionnaire [27] 
1992 C. DiIorio, M. Parsons, S. Lehr, D 
Adame and J. Carlone 
USA 531 college freshmen 27-items 1: sexual behaviors, 2: 
condom usage, 3:  high risk 
sexual behaviors, 4: sexual 
communication and 
negotiation 
 .52 to .85 
(individual 
subscales) 
Multidimensional 
Condom Attitudes Scale 
[9] 
1994 M. Helweg-Larsen and B.E. Collins USA 239 undergraduate 
students 
Age ranged from 15 to 
35 years 
25-items 1: Reliability and 
Effectiveness, 2: Pleasure, 3: 
Identity Stigma, 4: 
Embarrassment About 
Negotiation and Use, 5: 
Embarrassment About 
.62 to .94 
(individual 
subscales) 
Table Click here to download Table Table 1_REV.docx 
Purchase,  
HIV-Antibody Testing 
Attitude Scale [10] 
1999 C.B. Boshamer and K.E. Bruce USA 156 heterosexual 
students 
Age ranged from 17 to 
37 years 
32-item  1: Friends concerns about 
HIV antibody testing, 2: 
Family concerns about HIV 
antibody testing, 3: Concern 
about public opinion of HIV 
antibody testing, 4: 
Concerns about 
confidentiality of HIV 
antibody testing  
.88 
Fear-of-AIDS Instrument 
[22] 
1999 R.A. Bell, F. Molitor and N.M. Flynn USA 608 men and women at 
the AIDS Foundation's 
anonymous HIV test site 
40-items 1: Infection Fear, 2: Partner 
Betrayal, 3: Economic 
Consequences, 4: Society's 
Response, 5: Testing 
Concerns, 6: Casual Contact, 
7: Medical Procedures, 8: 
Safe Sex Communication 
Apprehension 
.87 to .97 
(individual 
subscales) 
Risk-Taking 
Questionnaire [23] 
2000 E. Gullone, S. Moore, S. Moss and C. 
Boyd 
Australia 570 and 925 adolescents  
Age ranged from 11 to 
18 years 
22-items 1: thrill-seeking behaviors, 
2: rebellious behaviors, 3: 
reckless behaviors (having 
unprotected sex included), 4: 
antisocial behaviors 
.66 to .80 
(individual 
subscales) 
Specific Condom Use 
Self-efficacy Scales [19] 
2001 J. Baele, E. Dusseldorp and S. Maes Belgium 424 male and female 
sexually experienced 
and inexperienced 
adolescents 
Average age of 17 years 
37-items 1: technical skills, 2: image 
confidence, 3: emotion 
control, 4: purchase, 5: 
assertiveness, 6: sexual 
control 
.65 to .84 
(individual 
subscales) 
Brief HIV Knowledge 
Questionnaire [16] 
2002 M.P. Carey and K.E.E. Schroder USA 1019 low-income men 
and women 
Average age of 33.99 
years 
18-items Unidimensional 0.75 to 0.89 
(across 
samples) 
Condom Influence 
Strategy Questionnaire 
[28] 
2002 S.M. Noar, P.J. Morokoff and L.L. 
Harlow 
USA 625 college students 
Age ranged from 18 to 
22 years 
36-items 1: Withholding sex, 2: 
Direct request, 3: Seduction, 
4: Relationship 
conceptualizing, 5: Risk 
.83 to .93 
(individual 
subscales) 
(STD) information, 6: 
Deception 
Modified Condom 
Outcome 
Expectancy Scale [20] 
2003 S.G. Sherman, D.A. Celentano, J.W. 
McGrath, S.E. Chard, R.R. 
Gangakhedkar, N. Joglekar, R. 
Malhotra-Kohli, M. Kamya and A. 
Fullen 
USA 100 HIV-negative 
sexual partners of HIV-
infected individuals 
 
9-items Two-factors analogous to 
two of the five factors in the 
original COES (partner 
reaction and positive self-
evaluation) 
.80 
HIV Risk Behavior 
Questionnaire [29] 
2005 J. Whyte USA 304 African American 
women 
Average age of 23.8 
years 
25-items 1: barrier/fluid avoidance 
modalities, 2: survival sex, 
3: sexual communications, 
4: factors that increase 
sexual risk 
.82 
HIV/AIDS Attitudes [11] 2007 N. Silva, P. Henrique, C. Henrique 
and N.M. Silva 
Brazil 549 high and elementary 
school level students 
Age ranged from 13 to 
51 years 
47-item 1: Technical / Scientific 
Information Perception 
General Factor, 2: Technical 
/ Scientific Information  
Perception Factor versus 
Sexuality and Prejudice, 3: 
Technical / Scientific 
Information 
Perception Factor in Drug 
Abuse 
.859 
Worry about sexual 
outcomes [26] 
2009 J.M. Sales, J. Spitalnick, R.R. 
Milhausen, G.M. Wingood, R.J. 
DiClemente, L.F. Salazar and R.A. 
Crosby 
USA 522 African-American 
female adolescents  
Age ranged from 14 to 
18 years 
10-items 1: STI/HIV worry, 2: 
pregnancy worry 
.87 
Perceived Risk of HIV 
Scale [24] 
2012 L.E. Napper, D.G. Fisher and G.L. 
Reynolds 
USA 785 clients of HIV 
testing and prevention 
services 
Age ranged from 18 to 
79 years 
8-items Unidimensional .88 
Multicomponent 
AIDS Phobia Scale [25] 
2013 J.P. Espada, M.T. Gonzálvez, M. 
Orgilés and A. Morales 
Spain 832 secondary students  
Age ranged from 14 to 
18 years 
20-items Two-factor .77 
HIV Attitudes Scale [15] 2013 J.P. Espada, R. Ballester, T.B. Huedo-
Medina, R. Secades-Vill, M. Orgilés 
Spain 1216 high school 
students 
12-items 1: Attitudes toward safe sex 
when there are obstacles; 2: 
.77 
and M. Martínez-Lorca Age ranged from 15 to 
17 years 
Attitudes toward HIV 
testing; 3: Attitudes toward 
condom use; 4: Attitudes 
toward people living with 
HIV/AIDS 
HIV/AIDS Stigma Scale 
[12] 
2014 E.A. Smith, J.A. Miller, V. Newsome,  
Y.A. Sofolahan and C.O. 
Airhihenbuwa 
USA 1195 South Africans 
Average age of 35.8 
years 
12-items 1: Government 
Support, 2: Shame and 
Rejection, 3: Individual 
Support 
.67 to .80 
(individual 
subscales) 
HIV and other STI 
Knowledge Scale [17] 
2014 J.P. Espada, A. Guillén-Riquelme, A. 
Morales, M. Orgilés and J.C. Sierra 
Spain 1570 adolescents 
Age ranged from 13 to 
17 years 
24-items 1: General knowledge about 
HIV, 2: Condom as a 
protective method, 3: Routes 
of HIV transmission, 4: 
prevention of HIV, and 5: 
other sexually transmitted 
infections 
0.65 to 0.85 
(individual 
subscales) 
Condom Use Expectancy 
Scale [13] 
2015 L.A. Nydegger, S.L. Ames and A.W. 
Stacy 
USA 440 people in drug 
programs  
18-items 1: Positive outcomes, 2: 
Negative 
Outcomes, 3: Safe sex 
outcomes 
.73 to .93 
(individual 
subscales) 
Condom Use Self-
efficacy Measure [21] 
2016 B.E. McCabe, N. Schaefer, K. 
Gattamorta, N. Villegas, R. Cianelli, 
V.B. Mitrani and N. Peragallo 
USA 320 Hispanic women 15-items Unidimensional .92 
HIV-Risk Index [30] 2016 R. Ballester-Arnal, M.D. Gil-Llario, 
J. Castro-Calvo and C. Giménez-
García 
Spain 9861 young people 
Age ranged from 18 to 
30 years 
9-items 1: direct sexual risk 
indicators, 2:indirect sexual 
risk indicators 
.79 
Condom Barriers and 
Motivations Scale 
2017 S.A. Golub and K.E. Gamarel USA 473 men who reported 
not taking PrEP and  
301 men elected to 
begin PrEP 
Average age of 32.99 
and 33.91 years 
16-items 1: Pleasure reduction 
barriers, 2: Perceived partner 
pressure barriers, 3: Risk 
reduction motivations, 4: 
Intimacy interference 
barriers 
0.74 to 0.83 
(individual 
subscales) 
 
Appendix 1. Answer sheet and correction criteria of the AIDS Prevention Questionnaire in 
Spanish language. 
 
1. ¿Has recibido en alguna ocasión información sobre alguno de los siguientes temas?  
 Sí No 
1.1.  Sexualidad 1 0 
1.2.  Métodos anticonceptivos    1 0 
1.3.  Infecciones de trasmisión sexual     1 0 
1.4.  VIH/SIDA     1 0 
 
2. ¿Cómo consideras tu nivel de información y conocimiento sobre la prevención del VIH/Sida?    
Malo Regular Bueno Muy bueno 
0 1 2 3 
 
3. ¿De quién o cómo has obtenido información acerca del VIH/Sida? 
 Si No 
3.1. Padre o madre 1 0 
3.2. Amigos 1 0 
3.3. Profesores 1 0 
3.4. Charlas o talleres formativos  1 0 
3.5. Campañas informativas 1 0 
 
4. ¿A través de cuáles de las siguientes prácticas sexuales se puede transmitir el VIH si no se 
utiliza el preservativo? 
 Si No 
4.1. Masturbaciones mutuas 0 1 
4.2. Sexo oral 1 0 
4.3. Coito vaginal 1 0 
4.4. Coito anal 1 0 
 
 Si No 
5. ¿Me pueden transmitir el VIH si practico únicamente el sexo oral? 1 0 
6. ¿Es la marcha atrás, es decir, retirar el pene antes de la eyaculación, un método 
eficaz para prevenir la transmisión del VIH? 
0 1 
Table Click here to download Table Appendix 1_REV.docx 
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7. ¿A simple vista se puede saber si una persona es portadora del VIH? 0 1 
8. ¿Una persona afectada por el VIH puede transmitir la infección aunque no 
presente síntomas? 
1 0 
9. ¿La mayoría de las personas que conviven con el VIH muestran síntomas de 
estar enfermos enseguida? 
0 1 
10. ¿Sabes dónde puedes realizarte las pruebas diagnósticas del VIH? 1 0 
11. ¿Dar positivo en estas pruebas implica desarrollar el SIDA con posterioridad? 0 1 
12. ¿Conoces la existencia de un periodo ventana para la realización de las pruebas 
diagnósticas del VIH?  
1 0 
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13. Me siento/sentiría cómodo/a o seguro/a a la hora de 1 2 3 4 5 
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comprar preservativos 
14. Me resultaría cómodo hablar acerca de la utilización del 
preservativo con una pareja antes de comenzar la relación 
sexual 
1 2 3 4 5 
15. Si tengo que sugerir a una pareja que usemos el 
preservativo, tengo/tendría miedo de que él/ella me rechace 
5 4 3 2 1 
16. No me siento/sentiría seguro/a a la hora de sugerir el 
uso del preservativo a una nueva pareja ya que él /ella 
podría pensar que lo hago porque creo que tiene una ITS 
5 4 3 2 1 
17. Estoy seguro/a de que recordaría utilizar el preservativo 
aunque haya consumido alcohol u otras drogas 
1 2 3 4 5 
18. Me siento/sentiría incómodo/a a la hora de ponerme el 
condón o ponérselo a mi pareja 
5 4 3 2 1 
19. Estoy seguro de que podría parar aún en el momento de 
mayor excitación para ponerme el condón o ponérselo a mi 
pareja 
1 2 3 4 5 
20. Sé cómo utilizar el preservativo en mis relaciones 
sexuales 
1 2 3 4 5 
21. Sé en qué aspectos tengo que fijarme para el uso del 
preservativo. 
1 2 3 4 5 
 
22. Señala de 0 a 100 la probabilidad o el riego que percibes de infectarte con el VIH: ______ 
 
23. Señala de 0 a 100 el temor que te produce la posibilidad de infectarte con el VIH: ______ 
 
24. Dirías que el VIH/Sida es una enfermedad: 
Leve Moderada Grave Fatal 
0 1 2 3 
 
25. ¿Hasta qué punto consideras el preservativo como un método fiable de prevención sexual 
del VIH?    
Nada Algo Bastante Mucho 
0 1 2 3 
 
 Sí No 
26. ¿Entre la mayoría de la gente importante para ti está bien visto el uso del 1 0 
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preservativo?    
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27. ¿Con qué frecuencia tienes la intención de utilizar el 
preservativo en el coito vaginal? 
0 1 2 3 
28. ¿Con qué frecuencia tienes la intención de utilizar el 
preservativo en el sexo oral? 
0 1 2 3 
29. ¿Con qué frecuencia tienes la intención de utilizar el 
preservativo en el coito anal? 
0 1 2 3 
30. ¿Con qué frecuencia tienes la intención de utilizar el 
preservativo en relaciones con pareja estable? 
0 1 2 3 
31. ¿Con qué frecuencia tienes la intención de utilizar el 
preservativo en relaciones con pareja esporádica? 
0 1 2 3 
32. ¿Con qué frecuencia tienes la intención de utilizar el 
preservativo cuando has consumido alcohol o drogas? 
0 1 2 3 
33. ¿Con qué frecuencia utilizas el preservativo en el coito 
vaginal? 
0 1 2 3 
34. ¿Con qué frecuencia utilizas el preservativo en el sexo oral? 0 1 2 3 
35. ¿Con qué frecuencia utilizas el preservativo en el coito anal? 0 1 2 3 
36. ¿Con qué frecuencia utilizas el preservativo en relaciones con 
pareja estable? 
0 1 2 3 
37. ¿Con qué frecuencia utilizas el preservativo en relaciones con 
pareja esporádica? 
0 1 2 3 
38. ¿Con qué frecuencia utilizas el preservativo cuando has 
consumido alcohol o drogas? 
0 1 2 3 
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 Sí No 
39. ¿Te has realizado la prueba diagnóstica del VIH alguna vez? 1 0 
 
40. En una escala de 0 a 100 ¿cuánto dirías que sufre un enfermo con VIH desde el punto de 
vista físico y social?: _____ 
 
41. En una escala de 0 a 100, ¿hasta qué punto piensas que la sociedad deberías ser más 
comprensiva y solidaria con los enfermos de VIH?: _____ 
 
 Sí No 
42. ¿Dejarías de ver por completo a un amigo si te enteraras que tiene VIH/Sida?    0 1 
43. ¿Cuidarías de un amigo que tuviera VIH/Sida? 1 0 
44. ¿Evitarías conocer a una persona que sabes que tiene VIH/Sida? 0 1 
 
Sistema de corrección del cuestionario. 
 
Se pueden calcular cinco subescalas a partir del siguiente sistema: 
Información y conocimientos sobre 
VIH 
Sumar ítems 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 
Las puntuaciones deben oscilar entre 0 y 24 
Autoeficacia y actitudes hacia el uso 
del preservativo  
Sumar ítems 13, 14, 15, 16, 17, 18, 19, 20, 21 
Las puntuaciones deben oscilar entre 9 y 54 
Intención de uso del preservativo Sumar ítems 27, 28, 29, 30, 31, 32 
Las puntuaciones deben oscilar entre 0 y 18 
Conducta sexual segura Sumar ítems 33, 34, 35, 36, 37, 38 
Las puntuaciones deben oscilar entre 0 y 18 
Solidaridad y empatía hacia las 
personas afectadas por VIH 
Sumar ítems 40, 41, 42, 43, 44 
Las puntuaciones deben oscilar entre 0 y 206 
 
Otra información 
 
El cuestionario ofrece ítems complementarios que evalúan otros factores relevantes en 
la prevención del VIH: 
- Ítem 22 y 23: vulnerabilidad percibida y temor percibido a la infección por VIH. 
- Ítem 24: gravedad percibida a la infección por VIH. 
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- Ítem 25: confianza en el uso del preservativo. 
- Ítem 26: norma percibida. 
- Ítem 39: realización de las pruebas de detección de VIH. 
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Appendix 2. Answer sheet and correction criteria of the AIDS Prevention Questionnaire in 
English language. 
 
1. Have you ever received information about any of the following topics?  
 Yes No 
1.1. Sexuality 1 0 
1.2. Methods of contraception 1 0 
1.3.  Sexually transmitted infections  1 0 
1.4.  HIV-AIDS 1 0 
 
2. How would you rate your level of knowledge about HIV-AIDS prevention?  
Bad Regular Good Very good 
0 1 2 3 
 
3. How did you get information about HIV-AIDS? 
 Yes No 
3.1. From parents 1 0 
3.2. From friends 1 0 
3.3. From teachers 1 0 
3.4. From talks and workshops on prevention 1 0 
3.5. From information campaigns 1 0 
 
4. If the condom is not used, by which of the following sexual practices can HIV be 
transmitted? 
 Yes No 
4.1. Mutual masturbation 0 1 
4.2. Oral sex 1 0 
4.3. Vaginal sex 1 0 
4.4. Anal sex 1 0 
 
 Yes No 
5. Can HIV be transmitted if only oral sex is practiced? 1 0 
6. Is the pulling out method, that is, when the penis is removed before ejaculation, 
an effective method to prevent the transmission of HIV? 
0 1 
7. At first sight, Can I identify if somebody is HIV-positive? 0 1 
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8. Can a HIV-positive person transmit the virus if he/she does not show 
symptoms? 
1 0 
9. Do most people living with HIV show symptoms of being sick right away? 0 1 
10. Do you know where you can be tested for HIV? 1 0 
11. HIV-positive result implies to develop AIDS later? 0 1 
12. Do you know the existence of a window period for checking the HIV 
antibody test?  
1 0 
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13. I feel or I would feel comfortable when 
buying condoms. 
1 2 3 4 5 
14. I feel or I would feel comfortable to talk 
about the use of condoms with a partner 
before beginning sexual intercourse. 
1 2 3 4 5 
15. If I have to suggest to a partner condom 
use, I feel or I would feel afraid of him/her 
rejecting me. 
5 4 3 2 1 
16. I do not feel or I would not feel safe when 
suggesting the use of condoms to a new 
partner, because he/she might think that I have 
an STI. 
5 4 3 2 1 
17. I am sure that I would remember to use the 
condom although I have consumed alcohol or 
other drugs. 
1 2 3 4 5 
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18. I feel or I would feel uncomfortable when 
I put the condom on or put it on my partner. 
5 4 3 2 1 
19. I am sure that I could stop to put on the 
condom or put it on my partner regardless of 
the moment of greater excitement. 
1 2 3 4 5 
20. I know how to use condoms in my sexual 
relationships. 
1 2 3 4 5 
21. I know in what aspects I have to pay 
attention when I use condoms. 
1 2 3 4 5 
 
22. Indicate from 0 to 100 the probability or risk you perceive of being able to contract HIV: 
______ 
 
23. Indicate from 0 to 100 the fear that you feel towards the possibility of contract HIV: ______ 
 
24. The HIV-AIDS is a disease: 
Mild Moderate Serious Fatal 
0 1 2 3 
 
25. Do you consider condoms as a reliable method for HIV sexual prevention? 
None Somewhat Quite Much 
0 1 2 3 
 
 Yes No 
26. Is condom use viewed favorably by most of the important people to you? 1 0 
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27. How often do you intend to use condoms in the coming 
vaginal intercourse? 
0 1 2 3 
28. How often do you intend to use condoms in the coming oral 
sex practice? 
0 1 2 3 
29. How often do you intend to use condoms in the coming anal 
intercourse? 
0 1 2 3 
30. How often do you intend to use condoms in the coming 
relationships with a steady partner? 
0 1 2 3 
31. How often do you intend to use condoms in the coming 
relationships with a sporadic partner? 
0 1 2 3 
32. How often do you intend to use condoms in the coming 
relationships under the effects of alcohol or drugs consumption? 
0 1 2 3 
33. How often do you use condoms in vaginal intercourse? 0 1 2 3 
34. How often do you use condoms in oral sex? 0 1 2 3 
35. How often do you use condoms in anal intercourse? 0 1 2 3 
36. How often do you use condoms in relationships with a steady 
partner? 
0 1 2 3 
37. How often do you use condoms in relationships with sporadic 
partners? 
0 1 2 3 
38. How often do you use a condom under the effects of alcohol 
or drugs consumption? 
0 1 2 3 
 
 Yes No 
39. Have you ever got an HIV antibody test? 1 0 
 
40. On a scale from 0 to 100, how much do you think an HIV-positive person suffers socially 
and physically?  _____ 
 
41. On a scale from 0 to 100, how much do you think society should be more understanding and 
supportive of HIV-positive people? _____ 
 
 Yes No 
42. Would you stop meeting with a friend if you found out that he/she is HIV-
positive? 
0 1 
43. Would you take care for a HIV-positive friend? 1 0 
44. Would you avoid meeting HIV-positive someone? 0 1 
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Scoring 
 
Five subscales scores can be calculated from following system: 
Knowledge about HIV (K-HIV) Add items 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 
Scores should range between 0 and 24 
Self-efficacy and attitudes (SEA) 
 
Add items 13, 14, 15, 16, 17, 18, 19, 20, 21 
Scores should range between 9 and 54 
Condom Use Intentions (CUSEI) Add items 27, 28, 29, 30, 31, 32 
Scores should range between 0 and 18 
Safe sexual behavior (SAS-B) Add items 33, 34, 35, 36, 37, 38 
Scores should range between 0 and 18 
Stigma and discrimination towards 
people living with HIV (SD-HIV) 
Add items 40, 41, 42, 43, 44 
Scores should range between 0 and 206 
 
Other information 
 
The questionnaire offers complementary items that measure other factors relevant to 
HIV prevention: 
- Item 22 and 23: perceived susceptibility and perceived threat of HIV 
- Item 24: perceived seriousness of HIV. 
- Item 25: trust on condom use. 
- Item 26: perceived norm. 
- Item 39: HIV testing behavior. 
  
 
 
